Literature DB >> 16611078

Inhibition of fatty acid synthase by polyphenols.

Wei-Xi Tian1.   

Abstract

Recently, animal fatty acid synthase (FAS) is reported as a potential therapeutic target for obesity and cancer. Considerable interest has been developed in identifying novel inhibitors of the enzyme. It is found that tea polyphenols inhibit FAS in both reversible and irreversible manners. Epigallocatechin gallate (EGCG) and epicatechin gallate (ECG) inhibit FAS with IC(50) values of 52 microM and 42 microM mainly by reacting on the beta-ketoacyl reductase (KR) domain of FAS. The inhibitory ability of catechin gallate (CG) is 15 and 12 folds higher than that of EGCG and ECG. Its major reacting site on FAS is not KR. All of these irreversibly inactivate FAS on the KR domain with similar rates. Mulliken population analysis suggests that the positive charge is distributed on the carbon atom of galloyl ester, and this carbon becomes more susceptible for a nucleophilic attack. 12 flavonoids inhibit FAS with IC(50) values ranging from 2 to 112 microM. SAR analysis shows that the flavonoids containing two hydroxyl groups in B ring and 5, 7-hydroxyl groups in A ring with C-2, 3 double bond are the most potent inhibitors. The inhibition kinetics shows that they inhibit FAS competitively with acetyl CoA and most likely react mainly on acyl transferase domain. Further studies show that C ring of flavonoids is not necessary for the inhibition. Resveratrol, phlorizin and NDGA contain two phenyl rings connected by 2 to 4 atom chains instead of C ring. Their IC(50) values range from 5 microM to 40 microM. From these results, a common model for polyphenol inhibitor of FAS is conceived.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16611078     DOI: 10.2174/092986706776361012

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  27 in total

Review 1.  Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease.

Authors:  Hui Dong; Fu-Er Lu; Li Zhao
Journal:  Chin J Integr Med       Date:  2012-02-05       Impact factor: 1.978

2.  A new model system swims into focus: using the zebrafish to visualize intestinal metabolism in vivo.

Authors:  Juliana D Carten; Steven A Farber
Journal:  Clin Lipidol       Date:  2009-08-01

Review 3.  The role of sex steroid receptors on lipogenesis in breast and prostate carcinogenesis: a viewpoint.

Authors:  Henri Rochefort; Dany Chalbos
Journal:  Horm Cancer       Date:  2010-04       Impact factor: 3.869

Review 4.  Fatty acid synthase as a potential therapeutic target in cancer.

Authors:  Richard Flavin; Stephane Peluso; Paul L Nguyen; Massimo Loda
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

5.  In silico investigation of lavandulyl flavonoids for the development of potent fatty acid synthase-inhibitory prototypes.

Authors:  Joonseok Oh; Haining Liu; Hyun Bong Park; Daneel Ferreira; Gil-Saeng Jeong; Mark T Hamann; Robert J Doerksen; MinKyun Na
Journal:  Biochim Biophys Acta Gen Subj       Date:  2016-08-13       Impact factor: 3.770

Review 6.  Zebrafish lipid metabolism: from mediating early patterning to the metabolism of dietary fat and cholesterol.

Authors:  Jennifer L Anderson; Juliana D Carten; Steven A Farber
Journal:  Methods Cell Biol       Date:  2011       Impact factor: 1.441

7.  Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker.

Authors:  Hailan Liu; Jing-Yuan Liu; Xi Wu; Jian-Ting Zhang
Journal:  Int J Biochem Mol Biol       Date:  2010-07-18

Review 8.  The importance of NAD in multiple sclerosis.

Authors:  W Todd Penberthy; Ikuo Tsunoda
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 9.  Signal transduction and molecular targets of selected flavonoids.

Authors:  Ann M Bode; Zigang Dong
Journal:  Antioxid Redox Signal       Date:  2013-04-15       Impact factor: 8.401

Review 10.  The potential of ¹¹C-acetate PET for monitoring the Fatty acid synthesis pathway in Tumors.

Authors:  Laura M Deford-Watts; Akiva Mintz; Steven J Kridel
Journal:  Curr Pharm Biotechnol       Date:  2013       Impact factor: 2.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.